Physico-chemical characterization, preparation and performance of poly (methylidene malonate 2.1.2) nanoparticles

被引:12
作者
Breton, P
Guillon, X
Roy, D
Lescure, F
Riess, G
Bru, N
Roques-Carmes, C
机构
[1] VIRSOL, F-75116 Paris, France
[2] Lab UPSA, Lab Rech Galen & Preformulat, F-92506 Rueil Malmaison, France
[3] Ecole Natl Super Chim, Lab Chim Macromol, F-68093 Mulhouse, France
[4] Ecole Natl Super Mecan & Microtech, Lab Microanal Surfaces, F-25030 Besancon, France
关键词
colloid physico-chemical analysis; colloidal drug carriers; MALDI-TOF spectroscopy; nanoparticles; poly(methylidene malonate); scanning electron microscopy;
D O I
10.1016/S0142-9612(97)00243-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The present investigation confirms that initially implemented procedure to produce poly(methylidene malonate 2.1.2) (PMM 2.1.2) nanoparticles (Lescure et al. Pharm Res 1994;11:1270-77) lead to products mostly containing plasticizing oligomers which strongly lowered glass-transition temperature (T-g), dramatically reduced nanoparticle consistency and rendered them too sensitive to solubilization when diluted in an aqueous medium. From MALDI-TOF spectroscopy analysis, performed on intact colloids, emerged some structural information about these oligomeric species which could result from an intramolecular cyclization mechanism occurring soon in the course of the polymerization process. Thus, with the objective of overcoming these drawbacks, this contribution deals with the variations of manufacturing specifications such as pH and magnetic stirring speed to try and modulate molecular weight (M-w) of nanoparticle constituents and reduce oligomer concentration. Although the analyses performed on these new nanoparticles were rather encouraging, the colloid formation yield became so low that it required the developement of other methodologies, excluding a previous emulsion step, and allowing a controlled production of PMM 2.1.2-made nanoparticles having better physico-chemical characteristics while keeping good pharmaceutical capabilities. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:271 / 281
页数:11
相关论文
共 41 条
[31]  
MULLER AHE, 1986, MAKROMOL CHEM, V187, P1473
[32]  
PICHOT C, 1987, B SOC CHIM FR, P725
[33]  
PIEJKO KE, 1982, MAKROMOL CHEM-RAPID, V3, P243
[34]   On shelf stability of freeze-dried poly(methylidene malonate 2.1.2) nanoparticles [J].
Roy, D ;
Guillon, X ;
Lescure, F ;
Couvreur, P ;
Bru, N ;
Breton, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (02) :165-175
[35]  
SCHREIBER H, 1959, MAKROMOLEKUL CHEM, V36, P86
[36]   ANTISENSE OLIGONUCLEOTIDES ADSORBED TO POLYALKYLCYANOACRYLATE NANOPARTICLES SPECIFICALLY INHIBIT MUTATED HA-RAS-MEDIATED CELL-PROLIFERATION AND TUMORIGENICITY IN NUDE-MICE [J].
SCHWAB, G ;
CHAVANY, C ;
DUROUX, I ;
GOUBIN, G ;
LEBEAU, J ;
HELENE, C ;
SAISONBEHMOARAS, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) :10460-10464
[37]  
VANDERHOFF JW, 1985, J POLYM SCI POL SYM, P161
[38]  
VANSNICK L, 1985, PHARMACEUT RES, P36, DOI 10.1023/A:1016366022712
[39]  
Vauthier-Holtzscherer C., 1991, STP PHARM SCI, V1, P109
[40]   SYNTHETIC DELIVERY SYSTEM FOR TUBERCULOSIS VACCINES - IMMUNOLOGICAL EVALUATION OF THE MYCOBACTERIUM-TUBERCULOSIS 38 KDA PROTEIN ENTRAPPED IN BIODEGRADABLE PLG MICROPARTICLES [J].
VORDERMEIER, HM ;
COOMBES, AGA ;
JENKINS, P ;
MCGEE, JP ;
OHAGAN, DT ;
DAVIS, SS ;
SINGH, M .
VACCINE, 1995, 13 (16) :1576-1582